Lemonade (LMND) Competitors $32.81 -0.19 (-0.58%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends LMND vs. BNRE, VOYA, JXN, ESNT, FG, ACT, BWIN, GSHD, OSCR, and HGTYShould you be buying Lemonade stock or one of its competitors? The main competitors of Lemonade include Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), F&G Annuities & Life (FG), Enact (ACT), The Baldwin Insurance Group (BWIN), Goosehead Insurance (GSHD), Oscar Health (OSCR), and Hagerty (HGTY). These companies are all part of the "insurance" industry. Lemonade vs. Brookfield Reinsurance Voya Financial Jackson Financial Essent Group F&G Annuities & Life Enact The Baldwin Insurance Group Goosehead Insurance Oscar Health Hagerty Brookfield Reinsurance (NYSE:BNRE) and Lemonade (NYSE:LMND) are both mid-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends. Does the MarketBeat Community prefer BNRE or LMND? Lemonade received 28 more outperform votes than Brookfield Reinsurance when rated by MarketBeat users. Likewise, 29.47% of users gave Lemonade an outperform vote while only 0.00% of users gave Brookfield Reinsurance an outperform vote. CompanyUnderperformOutperformBrookfield ReinsuranceOutperform VotesNo VotesUnderperform Votes2100.00% LemonadeOutperform Votes2829.47% Underperform Votes6770.53% Do analysts recommend BNRE or LMND? Lemonade has a consensus price target of $32.67, suggesting a potential downside of 0.43%. Given Lemonade's stronger consensus rating and higher probable upside, analysts clearly believe Lemonade is more favorable than Brookfield Reinsurance.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brookfield Reinsurance 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lemonade 3 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67 Which has stronger valuation & earnings, BNRE or LMND? Brookfield Reinsurance has higher revenue and earnings than Lemonade. Lemonade is trading at a lower price-to-earnings ratio than Brookfield Reinsurance, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrookfield Reinsurance$9.35B0.90$796M$0.29200.38Lemonade$429.80M5.45-$236.90M-$3.04-10.79 Does the media prefer BNRE or LMND? In the previous week, Lemonade had 1 more articles in the media than Brookfield Reinsurance. MarketBeat recorded 1 mentions for Lemonade and 0 mentions for Brookfield Reinsurance. Lemonade's average media sentiment score of 0.50 beat Brookfield Reinsurance's score of 0.00 indicating that Lemonade is being referred to more favorably in the news media. Company Overall Sentiment Brookfield Reinsurance Neutral Lemonade Positive Which has more risk and volatility, BNRE or LMND? Brookfield Reinsurance has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Comparatively, Lemonade has a beta of 2.17, suggesting that its stock price is 117% more volatile than the S&P 500. Do insiders & institutionals have more ownership in BNRE or LMND? 7.2% of Brookfield Reinsurance shares are held by institutional investors. Comparatively, 80.3% of Lemonade shares are held by institutional investors. 1.0% of Brookfield Reinsurance shares are held by company insiders. Comparatively, 12.5% of Lemonade shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is BNRE or LMND more profitable? Brookfield Reinsurance has a net margin of 0.10% compared to Lemonade's net margin of -43.51%. Brookfield Reinsurance's return on equity of 0.14% beat Lemonade's return on equity.Company Net Margins Return on Equity Return on Assets Brookfield Reinsurance0.10% 0.14% 0.01% Lemonade -43.51%-32.85%-12.59% SummaryLemonade beats Brookfield Reinsurance on 11 of the 18 factors compared between the two stocks. Get Lemonade News Delivered to You Automatically Sign up to receive the latest news and ratings for LMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LMND vs. The Competition Export to ExcelMetricLemonadeFire, marine, & casualty insurance IndustryFinance SectorNYSE ExchangeMarket Cap$2.31B$42.87B$11.31B$19.37BDividend YieldN/A6.72%5.84%3.71%P/E Ratio-10.799.0422.7034.03Price / Sales5.456.9828.5917.05Price / CashN/A17.9117.2719.84Price / Book3.242.242.655.76Net Income-$236.90M$4.03B$1.04B$993.25M7 Day Performance1.48%3.88%3.08%3.26%1 Month Performance-13.89%-0.37%1.54%5.71%1 Year Performance99.44%50.37%14.66%18.85% Lemonade Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LMNDLemonade3.62 of 5 stars$32.81-0.6%$32.67-0.4%+104.9%$2.31B$429.80M-10.791,258BNREBrookfield ReinsuranceN/A$55.03-5.6%N/A+50.0%$8.00B$9.35B189.774,000High Trading VolumeVOYAVoya Financial4.9937 of 5 stars$67.13+1.1%$84.73+26.2%-1.5%$6.46B$7.71B10.699,000Analyst ForecastJXNJackson Financial1.9083 of 5 stars$85.39+1.0%$92.40+8.2%+87.3%$6.31B$3.91B-6.763,500News CoverageESNTEssent Group4.2884 of 5 stars$55.05+1.0%$62.71+13.9%+8.1%$5.85B$1.23B7.98350Short Interest ↓FGF&G Annuities & Life1.538 of 5 stars$39.270.0%$46.50+18.4%+2.5%$4.95B$5.50B-654.391,165News CoverageACTEnactN/A$31.40+0.8%$35.00+11.5%+15.9%$4.82B$1.20B7.30500Analyst ForecastBWINThe Baldwin Insurance Group3.6834 of 5 stars$35.70-0.1%$46.00+28.9%N/A$4.20B$1.33B-55.783,927Analyst ForecastGSHDGoosehead Insurance3.3652 of 5 stars$101.27+2.7%$99.20-2.0%+48.0%$3.76B$283.60M140.651,430News CoverageOSCROscar Health3.8674 of 5 stars$14.16-0.1%$21.56+52.3%+44.3%$3.50B$8.22B-235.962,710News CoverageHGTYHagerty2.8495 of 5 stars$9.23-1.8%$11.00+19.2%+23.8%$3.15B$1.16B83.911,732News Coverage Related Companies and Tools Related Companies Brookfield Reinsurance Competitors Voya Financial Competitors Jackson Financial Competitors Essent Group Competitors F&G Annuities & Life Competitors Enact Competitors The Baldwin Insurance Group Competitors Goosehead Insurance Competitors Oscar Health Competitors Hagerty Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:LMND) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lemonade, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lemonade With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.